Abstract
New discoveries and technologies have begun to change paradigms of urothelial cancer therapy in recent years. One of the novel techniques which emerged in the imaging community is radiomics, which refers to the high-throughput extraction of quantitative image features from medical images. Radiomics, being noninvasive and easy to perform, has shown great potential in oncology by providing valuable information about tumor type, aggressiveness, progression, response to treatment and prognosis and enabling us to gain insights into the true utility of personalized medicine in the management of cancer in the near future. With rapid development in this area, radiomics has already been applied in urothelial cancer to predict pathological grade, clinical stage, lymph node metastasis and treatment response demonstrating promising results. In this review, we highlight advances in clinical applications of radiomics in urothelial cancer, discuss about the challenges and implications of radiomics for radiologists and suggest the future directions that we could move toward in order to fully realize the potentials of radiomics to improve personalized management of patients with urothelial cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
